Exposure of cardiomyocytes to angiotensin II induces over-activation of monoamine oxidase type A: Implications in heart failure

European Journal of Pharmacology

Volumn 718, Issue 1-3, 2013, Pages 271-276

  Manni, Maria Elena ^a   Zazzeri, Marina ^a   Musilli, Claudia ^a   Bigagli, Elisabetta ^a   Lodovici, Maura ^a   Raimondi, Laura ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Angiotensin type 1 receptor antagonist; Angiotensin II; Diabetic cardiomyopathy; Heart failure; Monoamine oxidase

Indexed keywords

ALDEHYDE DEHYDROGENASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CATALASE; IRBESARTAN; LOSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL IMMORTALIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGRADATION; DIABETIC CARDIOMYOPATHY; DRUG TARGETING; ENZYME ACTIVATION; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN TYPE 1 RECEPTOR ANTAGONIST; ANGIOTENSIN-II; DIABETIC CARDIOMYOPATHY; HEART FAILURE; MONOAMINE OXIDASE;

ALDEHYDE DEHYDROGENASE; ANGIOTENSIN II; ANIMALS; BIPHENYL COMPOUNDS; CATALASE; ENZYME ACTIVATION; HEART FAILURE; HYPERGLYCEMIA; LOSARTAN; MONOAMINE OXIDASE; MYOCYTES, CARDIAC; RATS; TETRAZOLES;

EID: 84887035251     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.08.022     Document Type: Article

References (31)

1. C. Alfarano, L. Sartiani, C. Nediani, E. Mannucci, A. Mugelli, E. Cerbai, and L. Raimondi Functional coupling of angiotensin II type 1 receptor with insulin resistance of energy substrate uptakes in immortalized cardiomyocytes (HL-1 cells) British Journal of Pharmacology 153 2008 907 914
2. C. Alfarano, S. Suffredini, O. Fantappiè, A. Mugelli, E. Cerbai, M.E. Manni, and L. Raimondi The effect of losartan treatment on the response of diabetic cardiomyocytes to ATP depletion Pharmacological Research 63 2011 225 232
3. P. Bianchi, O. Kunduzova, E. Masini, C. Cambon, D. Bani, L. Raimondi, M.H. Seguelas, S. Nistri, W. Colucci, N. Leducq, and A. Parini Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury Circulation 112 2005 3297 3305
4. P. Bianchi, D.R. Pimentel, M.P. Murphy, W.S. Colucci, and A. Parini A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation FASEB Journal 19 2005 641 643
5. G.R. Budas, M.H. Disatnik, and D. Mochly-Rosen Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target? Trends in Cardiovascular Medicine 19 1994 158 164
6. E. Cerbai, M. Barbieri, Q. Li, and A. Mugelli Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages Cardiovascular Research 28 1994 1180 1187
7. D.F. Dai, S.C. Johnson, J.J. Villarin, M.T. Chin, M. Nieves- Cintrón, T. Chen, D.J. Marcinek, G.W. Dorn, Y.J. Kang, T.A. Prolla, L.F. Santana, and P.S. Rabinovitch Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure Circulation Research 108 2011 837 846
8. S.N. Deftereos, E. Dodou, C. Andronis, and A. Persidis From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors Expert Review of Clinical Pharmacology 5 2012 413 425
9. F. Dong, C.X. Fang, X. Yang, X. Zhang, F.L. Lopez, and J. Ren Cardiac overexpression of catalase rescues cardiac contractile dysfunction induced by insulin resistance: role of oxidative stress, protein carbonyl formation and insulin sensitivity Diabetologia 49 2006 1421 1433
10. P. Failli, C. Alfarano, S. Franchi-Micheli, E. Mannucci, E. Cerbai, A. Mugelli, and L. Raimondi Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats Cardiovascular Diabetology 22 2009 832 842
11. J.L. Gayet, and G. Harish Optimal trial in myocardial infarction with the angiotensin II antagonist losartan the OPTIMAAL trial: losartan or captopril after acute myocardial infarction Lancet 360 2002 1884 1885
12. B.R. Goyal, K. Parmar, R.K. Goyal, and A.A. Mehta Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats Pharmacological Reports 63 2011 956 966
13. G. Harish, C. Venkateshappa, A. Mahadevan, N. Pruthi, M.M. Bharath, and S.K. Shankar Mitochondrial function in human brains is affected by pre- and post mortem factors Neuropathology and applied neurobiology 39 2013 298 315
14. S. Ozdemir, B. Tandogan, N.N. Ulusu, and B. Turan Angiotensin II Receptor Blockage Prevents Diabetes-Induced Oxidative Damage in Rat Heart Folia Biologica (Praha) 55 2009 11 16
15. N. Kaludercic, E. Takimoto, T. Nagayama, N. Feng, E.W. Lai, D. Bedja, K. Chen, K.L. Gabrielson, R.D. Blakely, J.C. Shih, K. Pacak, D.A. Kass, F. Di Lisa, and N. Paolocci Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload Circulation Research 106 2010 193 202
16. H. Luch Catalase H.U. Bergmeyer, Methods of Enzymatic Analysis 1965 Academic Press New York 885 894
17. M.E. Manni, E. Bigagli, M. Lodovici, M. Zazzeri, and L. Raimondi The protective effect of losartan in the nephropathy of the diabetic rat includes the control of monoamine oxidase type A activity Pharmacological Research 65 2012 465 471
18. C. Nediani, L. Raimondi, E. Borchi, and E. Cerbai Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: from molecular mechanisms to therapeutic implications Antioxidants and Redox Signaling 14 2011 289 331 (review)
19. J. Petrak, J. Pospisilova, M. Sedinova, P. Jedelsky, L. Lorkova, O. Vit, M. Kolar, H. Strnad, J. Benes, D. Sedmera, L. Cervenka, and V. Melenovsky Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase Proteome Science 9 2011 69 10.1186/1477-5956-9-69
20. R. Pino, P. Failli, L. Mazzetti, and F. Buffoni Monoamine oxidase and semicarbazide-sensitive amine oxidase activities in isolated cardiomyocytes of spontaneously hypertensive rats Biochemical and Molecular Medicine 62 1997 188 196
21. C.M. Quinzii, C. Garone, V. Emmanuele, S. Tadesse, S. Krishna, B. Dorado, and M. Hirano Tissue-specific oxidative stress and loss of mitochondria in CoQ-deficient Pdss2 mutant mice FASEB Journal 27 2013 612 621
22. W. Raasch, T. Bartels, A. Gieselberg, A. Dendorfer, and P. Dominiak Angiotensin I-converting enzyme inhibition increases cardiac catecholamine content and reduces monoamine oxidase activity via an angiotensin type 1 receptor-mediated mechanism Journal of Pharmacology and Experimental Therapeutics 300 2002 428 434
23. L. Raimondi, G. Banchelli, L. Sgromo, R. Pirisino, M. Ner, A. Parini, and C. Cambon Hydrogen peroxide generation by monoamine oxidases in rat white adipocytes: role on cAMP production European Journal of Pharmacology 395 2000 177 182
24. L. Raimondi, P. De Paoli, E. Mannucci, G. Lonardo, L. Sartiani, and G. Banchelli Restoration of cardiomyocyte functional properties by angiotensin II receptor blockade in diabetic rats Diabetes 53 2004 927 933
25. L. Sartiani, P. Bochet, E. Cerbai, A. Mugelli, and R. Fishmeister Functional expression of the hyperpolarization-activated, non selective cation current I(f) in immortalized HL-1 cardiomyocytes Journal of Physiology 545 2002 81 92
26. J. Shi Monoamine oxidases: from tissue homogenates to transgenic mice Neurochemical Research 32 2007 1757 1761
27. S. Turdi, Q. Li, F.L. Lopez, and J. Ren Catalase alleviates cardiomyocyte dysfunction in diabetes: role of Akt, Forkhead transcriptional factor and silent information regulator Life Sciences 81 2007 895 905
28. P. Wenzel, U. Hink, M. Oelze, K. Schaeuble, S. Schildknecht, and K.K. Ho Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity Journal of Biological Chemistry 282 2007 792 799
29. C. Villeneuve, A. Caudrillier, C. Ordener, N. Pizzinat, A. Parini, and J. Mialet-Perez Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells American Journal of Physiology - Heart and Circulatory Physiology 297 2009 H821 828
30. C. Villeneuve, C. Guilbeau-Frugier, P. Sicard, O. Lairez, C. Ordener, T. Duparc, D. De Paulis, B. Couderc, O. Spreux-Varoquaux, F. Tortosa, A. Garnier, C. Knauf, P. Valet, E. Borchi, C. Nediani, A. Gharib, M. Ovize, M.B. Delisle, A. Parini, and J. Mialet-Perez p53-PGC-1α Pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice Antioxidants and Redox Signaling 18 2012 5 18
31. Y. Zhang, S.A. Babcock, N. Hu, J.R. Maris, H. Wang, and J. Ren Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function BMC Medicine 23 2012 10 40